LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

Amanda E.D. Van Swearingen, Carey K. Anders, Allison M. Deal et al.|Breast Cancer Research and Treatment|2018

Cited by 48